Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
NASDAQ:SCTL
Price:
1.1 USD
Market Closed
Updated:
May 29, 2024
Societal CDMO Inc
Accrued Liabilities
|
Societal CDMO Inc
Accrued Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Societal CDMO Inc
NASDAQ:SCTL
|
Accrued Liabilities
$11.4m
|
CAGR 3-Years
54%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
34%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accrued Liabilities
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accrued Liabilities
$9.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accrued Liabilities
$2.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accrued Liabilities
$13.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accrued Liabilities
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
See Also
What is Societal CDMO Inc's Accrued Liabilities?
Accrued Liabilities
11.4m
USD
11.4m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Accrued Liabilities amounts to 11.4m USD.
What is Societal CDMO Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
34%
34%
Over the last year, the Accrued Liabilities growth was -2%. The average annual Accrued Liabilities growth rates for Societal CDMO Inc have been 54% over the past three years , -4% over the past five years , and 34% over the past ten years .
You don't have any saved screeners yet
